Lymphoma, B-Cell

"Lymphoma, B-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.

Descriptor ID	D016393
MeSH Number(s)	C04.557.386.480.150 C15.604.515.569.480.150 C20.683.515.761.480.150
Concept/Terms	Lymphoma, B-Cell Lymphoma, B-Cell Lymphoma, B Cell B-Cell Lymphoma B Cell Lymphoma B-Cell Lymphomas Lymphomas, B-Cell

Below are MeSH descriptors whose meaning is more general than "Lymphoma, B-Cell".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, B-Cell [C04.557.386.480.150]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, B-Cell [C15.604.515.569.480.150]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, B-Cell [C20.683.515.761.480.150]

Below are MeSH descriptors whose meaning is related to "Lymphoma, B-Cell".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, B-Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, B-Cell" by people in this website by year, and whether "Lymphoma, B-Cell" was a major or minor topic of these publications.

Bar chart showing 63 publications over 25 distinct years, with a maximum of 5 publications in 1999 and 2006 and 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	1	3
1997	1	0	1
1999	3	2	5
2000	2	0	2
2001	1	2	3
2002	1	1	2
2003	3	1	4
2004	3	1	4
2005	2	0	2
2006	3	2	5
2007	3	0	3
2008	2	0	2
2009	3	0	3
2010	5	0	5
2011	1	0	1
2012	0	2	2
2014	3	0	3
2015	1	0	1
2016	1	0	1
2019	1	0	1
2020	1	0	1
2021	2	0	2
2022	2	0	2
2023	4	0	4
2024	1	0	1

Below are the most recent publications written about "Lymphoma, B-Cell" by people in Profiles.

Karmali R, Machhi R, Epperla N, Shouse G, Romancik J, Moyo TK, Kenkre V, Ollila TA, Fitzgerald L, Hess B, David K, Roy I, Zurko J, Chowdhury SM, Annunzio K, Ferdman R, Bhansali RS, Harris EI, Liu J, Nizamuddin I, Ma S, Moreira J, Winter J, Pro B, Stephens DM, Danilov A, Shah NN, Cohen JB, Barta SK, Torka P, Gordon LI. Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood Adv. 2024 05 28; 8(10):2592-2599.

View in: PubMed
Kolberg C, Doman E, Mignano S, Mullikin D, Vasta L, Wadzinski W, Foster B. Recognizing a Mediastinal Mass: A Case of Primary Mediastinal Large B-Cell Lymphoma With Pruritus in a 23-Year-Old Adult Male Sailor. Mil Med. 2023 11 03; 188(11-12):3687-3691.

View in: PubMed
Quaglino P, Pimpinelli N, Zinzani PL, Paulli M, Pileri S, Berti E, Cerroni L, Guitart J, Kim YH, Rupoli S, Santucci M, Simontacchi G, Vermeer M, Hoppe R, Pro B, Swerdlow SH, Barosi G. Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel. Hematol Oncol. 2024 Jan; 42(1):e3215.

View in: PubMed
Zurko J, Nizamuddin I, Epperla N, David K, Cohen JB, Moyo TK, Ollila T, Hess B, Roy I, Ferdman R, Liu J, Chowdhury SM, Romancik J, Bhansali RS, Harris EI, Sorrell M, Masel R, Kittai AS, Denlinger N, Sigmund AM, Fitzgerald L, Galvez C, Ma S, Winter J, Pro B, Gordon LI, Danilov A, Stephens D, Shah NN, Kenkre V, Barta SK, Torka P, Shouse G, Karmali R. Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL. Blood Adv. 2023 Jun 27; 7(12):2657-2669.

View in: PubMed
Altinkaynak M, Goksoy Y, Gonenli MG, Yegen G, Erten SN, Saka B, Akpinar TS. Cyclin-D1 positive B cell lymphoma with intravascular and interstitial involvement of kidney and bone marrow. Int J Hematol. 2023 Jun; 117(6):925-928.

View in: PubMed
Klimczak A, Scott RT. Reply of the Authors: B-cell lymphoma 6 (BCL6) testing before in vitro fertilization as a predictor of failure. Fertil Steril. 2022 08; 118(2):420.

View in: PubMed
Correia E, Cha J, Krishnasamy S, O'Donnell M, Shi W, Porcu P, Nikbakht N. A case series of primary cutaneous B-cell lymphomas with atypical presentations: diagnostic and therapeutic challenges. Haematologica. 2022 04 01; 107(4):1014-1016.

View in: PubMed
Andrews JM, Pyfrom SC, Schmidt JA, Koues OI, Kowalewski RA, Grams NR, Sun JJ, Berman LR, Duncavage EJ, Lee YS, Cashen AF, Oltz EM, Payton JE. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers. EBioMedicine. 2021 Sep; 71:103559.

View in: PubMed
Henry RK, Bilyk JR, Evans JJ, Lao PA, Milman T. Double-hit and triple-hit high-grade B-cell lymphoma of the ocular adnexa. Orbit. 2022 Oct; 41(5):624-628.

View in: PubMed
Okudolo JO, Bagg A, Meghpara BB, Sieber MR, Eagle RC, Milman T. Conjunctival Pediatric-Type Follicular Lymphoma. Ophthalmic Plast Reconstr Surg. 2020 Mar/Apr; 36(2):e46-e49.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement